The global spatial OMICS market market size is calculated at USD 339.98 million in 2025 and is forecasted to reach around USD 841.89 million by 2034, accelerating at a CAGR of 10.6% from 2025 to 2034. The North America spatial OMICS market market size surpassed USD 125.07 million in 2024 and is expanding at a CAGR of 10.7% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Spatial OMICS Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Spatial OMICS Market Revenue and Volume Forecast, by Application
8.1.1. Diagnostics
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Translation Research
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Drug Discovery and Development
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Single Cell Analysis
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Cell Biology
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Other
8.1.6.1. Market Revenue and Volume Forecast
9.1. Spatial OMICS Market Revenue and Volume Forecast, by Solution Type
9.1.1. Instruments
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Consumables
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Software
9.1.3.1. Market Revenue and Volume Forecast
10.1. Spatial OMICS Market Revenue and Volume Forecast, by Sample
10.1.1. DNA
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. RNA
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Protein
10.1.3.1. Market Revenue and Volume Forecast
11.1. Spatial OMICS Market Revenue and Volume Forecast, by End Users
11.1.1. Academic and Research Institutions
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Biopharmaceutical & Biotechnological Companies
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Contract Research Organization
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Other
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Application
12.1.2. Market Revenue and Volume Forecast, by Solution Type
12.1.3. Market Revenue and Volume Forecast, by Sample
12.1.4. Market Revenue and Volume Forecast, by End Users
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Application
12.1.5.2. Market Revenue and Volume Forecast, by Solution Type
12.1.5.3. Market Revenue and Volume Forecast, by Sample
12.1.5.4. Market Revenue and Volume Forecast, by End Users
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Application
12.1.6.2. Market Revenue and Volume Forecast, by Solution Type
12.1.6.3. Market Revenue and Volume Forecast, by Sample
12.1.6.4. Market Revenue and Volume Forecast, by End Users
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Application
12.2.2. Market Revenue and Volume Forecast, by Solution Type
12.2.3. Market Revenue and Volume Forecast, by Sample
12.2.4. Market Revenue and Volume Forecast, by End Users
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Application
12.2.5.2. Market Revenue and Volume Forecast, by Solution Type
12.2.5.3. Market Revenue and Volume Forecast, by Sample
12.2.5.4. Market Revenue and Volume Forecast, by End Users
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Application
12.2.6.2. Market Revenue and Volume Forecast, by Solution Type
12.2.6.3. Market Revenue and Volume Forecast, by Sample
12.2.6.4. Market Revenue and Volume Forecast, by End Users
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Application
12.2.7.2. Market Revenue and Volume Forecast, by Solution Type
12.2.7.3. Market Revenue and Volume Forecast, by Sample
12.2.7.4. Market Revenue and Volume Forecast, by End Users
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Application
12.2.8.2. Market Revenue and Volume Forecast, by Solution Type
12.2.8.3. Market Revenue and Volume Forecast, by Sample
12.2.8.4. Market Revenue and Volume Forecast, by End Users
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Application
12.3.2. Market Revenue and Volume Forecast, by Solution Type
12.3.3. Market Revenue and Volume Forecast, by Sample
12.3.4. Market Revenue and Volume Forecast, by End Users
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Application
12.3.5.2. Market Revenue and Volume Forecast, by Solution Type
12.3.5.3. Market Revenue and Volume Forecast, by Sample
12.3.5.4. Market Revenue and Volume Forecast, by End Users
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Application
12.3.6.2. Market Revenue and Volume Forecast, by Solution Type
12.3.6.3. Market Revenue and Volume Forecast, by Sample
12.3.6.4. Market Revenue and Volume Forecast, by End Users
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Application
12.3.7.2. Market Revenue and Volume Forecast, by Solution Type
12.3.7.3. Market Revenue and Volume Forecast, by Sample
12.3.7.4. Market Revenue and Volume Forecast, by End Users
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Application
12.3.8.2. Market Revenue and Volume Forecast, by Solution Type
12.3.8.3. Market Revenue and Volume Forecast, by Sample
12.3.8.4. Market Revenue and Volume Forecast, by End Users
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Application
12.4.2. Market Revenue and Volume Forecast, by Solution Type
12.4.3. Market Revenue and Volume Forecast, by Sample
12.4.4. Market Revenue and Volume Forecast, by End Users
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Application
12.4.5.2. Market Revenue and Volume Forecast, by Solution Type
12.4.5.3. Market Revenue and Volume Forecast, by Sample
12.4.5.4. Market Revenue and Volume Forecast, by End Users
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Application
12.4.6.2. Market Revenue and Volume Forecast, by Solution Type
12.4.6.3. Market Revenue and Volume Forecast, by Sample
12.4.6.4. Market Revenue and Volume Forecast, by End Users
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Application
12.4.7.2. Market Revenue and Volume Forecast, by Solution Type
12.4.7.3. Market Revenue and Volume Forecast, by Sample
12.4.7.4. Market Revenue and Volume Forecast, by End Users
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Application
12.4.8.2. Market Revenue and Volume Forecast, by Solution Type
12.4.8.3. Market Revenue and Volume Forecast, by Sample
12.4.8.4. Market Revenue and Volume Forecast, by End Users
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Application
12.5.2. Market Revenue and Volume Forecast, by Solution Type
12.5.3. Market Revenue and Volume Forecast, by Sample
12.5.4. Market Revenue and Volume Forecast, by End Users
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Application
12.5.5.2. Market Revenue and Volume Forecast, by Solution Type
12.5.5.3. Market Revenue and Volume Forecast, by Sample
12.5.5.4. Market Revenue and Volume Forecast, by End Users
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Application
12.5.6.2. Market Revenue and Volume Forecast, by Solution Type
12.5.6.3. Market Revenue and Volume Forecast, by Sample
12.5.6.4. Market Revenue and Volume Forecast, by End Users
13.1. NanoString Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Illumina, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. 10x Genomics, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Akoya Biosciences, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Visiopharm A/S
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Fluidigm Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Advanced Cell Diagnostics, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. ZEISS Group
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample